Copyright Reports & Markets. All rights reserved.

Incontinence and Ostomy Care Global Market - Forecast to 2026

Request for Sample of this report
Buy now

1 EXECUTIVE SUMMARY 24

    2 INTRODUCTION 32

    • 2.1 KEY TAKEAWAYS 32
    • 2.2 SCOPE OF THE REPORT 33
    • 2.3 REPORT DESCRIPTION 33
    • 2.4 MARKETS COVERED 37
    • 2.5 STAKEHOLDERS 39
    • 2.6 RESEARCH METHODOLOGY 40
      • 2.6.1 MARKET SIZE ESTIMATION 41
      • 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 44
      • 2.6.3 SECONDARY SOURCES 45
      • 2.6.4 PRIMARY SOURCES 46
      • 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 46
      • 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 47
      • 2.6.7 ASSUMPTIONS 48
        • 2.6.7.1 AVERAGE SELLING PRICE ASSUMPTIONS 49

      3 MARKET ANALYSIS 50

      • 3.1 INTRODUCTION 50
      • 3.2 MARKET SEGMENTATION 52
      • 3.3 FACTORS INFLUENCING MARKET 54
        • 3.3.1 DRIVERS AND OPPORTUNITIES 55
          • 3.3.1.1 Increase in aging population 55
          • 3.3.1.2 Development of innovative and personalized products 56
          • 3.3.1.3 Increase in awareness and acceptance 57
          • 3.3.1.4 Increase in prevalence of chronic diseases 59
        • 3.3.2 RESTRAINTS AND THREATS 60
          • 3.3.2.1 Environment and disposal concerns 60
          • 3.3.2.2 Low cost manufactures 61
          • 3.3.2.3 Alternative medical treatment 61
          • 3.3.2.4 Limited reimbursement 62
      • 3.4 REGULATORY AFFAIRS 63
      • 3.4.1.1 ISO 9001: 2015 quality management system 63
      • 3.4.1.2 ISO 13485 medical devices 63
      • 3.4.1.3 ISO 10993 biological evaluation of medical devices 64
      • 3.4.1.4 ISO 14971 risk management of medical devices 64
      • 3.4.1.5 IEC 60601-1 medical electrical equipment standard 64
      • 3.4.1.6 IEC 60601-1-11 home care safety 65
    • 3.4.2 U.S. 65
    • 3.4.3 EUROPE 66
    • 3.4.4 JAPAN 66
    • 3.4.5 CHINA 67
    • 3.4.6 INDIA 67
  • 3.5 PATENT ANALYSIS 68
  • 3.6 TECHNOLOGICAL ADVANCEMENTS 70
    • 3.6.1 SMART DIAPERS 70
    • 3.6.2 SMART BAGS 70
    • 3.6.3 WEARBLE DIAPER FREE DEVICES (DFREE) 71
    • 3.6.4 WEARBLE PELVIC FLOOR MUSCLE STIMULATION DEVICES 71
    • 3.6.5 ADVANCEMENTS IN BIOMATERIALS 72
    • 3.6.6 INCREASED ABSORBENCE AND ANTIBACTERIAL SOLUTIONS 72
    • 3.6.7 MOLDABLE TECHNOLOGY 73
    • 3.6.8 NEXT GENERATION OSTOMY IMPLANTS 73
  • 3.7 PORTER’S FIVE FORCE ANALYSIS 75
    • 3.7.1 THREAT OF NEW ENTRANTS 76
    • 3.7.2 THREAT OF SUBSTITUTES 76
    • 3.7.3 BARGAINING POWER OF SUPPLIERS 77
    • 3.7.4 BARGAINING POWER OF BUYERS 78
    • 3.7.5 COMPETITIVE RIVALRY 78
  • 3.8 SUPPLY CHAIN ANALYSIS 80
  • 3.9 REIMBURSEMENT SCENARIO 85
  • 3.10 PIPELINE ANALYSIS 90
  • 3.11 INCONTINENCE AND OSTOMY CARE MARKET PENETRATION, PREVALENCE AND OPPORTUNITY 94
    • 3.11.1 ADULT DIAPERS MARKET PENETRATION, PREVALENCE AND OPPORTUNITY 94
    • 3.11.2 OSTOMY MARKET PENETRATION, PREVALENCE AND OPPORTUNITY 101
  • 3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 119
    • 3.12.1 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS 119
    • 3.12.2 INCONTINENCE CARE GLOBAL MARKET SHARE ANALYSIS 123
    • 3.12.3 OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS 127
    • 3.12.4 ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS 130
      • 3.12.4.1 North America adult diapers market share analysis 133
      • 3.12.4.2 Europe adult diapers market share analysis 136
      • 3.12.4.3 Asia-Pacific adult diapers market share analysis 138
      • 3.12.4.4 Rest of the world adult diapers market share analysis 140
  • 3.13 INCONTINENCE AND OSTOMY CARE COMPANY COMPARISON TABLE BY PRODUCT TYPE, PRODUCT NAME AND APPLICATION 142

    • 4 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY PRODUCT 147

    • 4.1 INTRODUCTION 147
    • 4.2 INCONTINENCE CARE 150
      • 4.2.1 INCONTINENCE CARE GLOBAL MARKET BY DISEASE TYPE 153
        • 4.2.1.1 Urinary incontinence 156
        • 4.2.1.2 Fecal incontinence 160
      • 4.2.2 INCONTINENCE CARE GLOBAL MARKET BY PRODUCT TYPE 163
        • 4.2.2.1 Disposables 166
        • 4.2.2.1.1 Adult diaper 171
        • 4.2.2.1.2 Incontinence catheter 186
        • 4.2.2.1.3 Incontinence bags 190
        • 4.2.2.1.4 Anal irrigation system 192
        • 4.2.2.1.5 Pessaries 194
        • 4.2.2.1.6 Other disposables 196
        • 4.2.2.2 Implant devices 198
        • 4.2.2.2.1 Sacral nerve stimulation (SNS) 202
        • 4.2.2.2.2 Tibial nerve stimulation (TNS) 204
        • 4.2.2.2.3 Artificial sphincters 206
        • 4.2.2.2.4 Slings 208
        • 4.3 OSTOMY CARE 210
          • 4.3.1 OSTOMY CARE GLOBAL MARKET BY SURGERY TYPE 212
            • 4.3.1.1 Colostomy 215
            • 4.3.1.2 Ileostomy 218
            • 4.3.1.3 Urostomy 220
          • 4.3.2 OSTOMY CARE GLOBAL MARKET BY PRODUCT TYPE 222
            • 4.3.2.1 Ostomy bags 225
            • 4.3.2.1.1 One-piece ostomy bags 228
            • 4.3.2.1.2 Two-piece ostomy bags 230
            • 4.3.2.2 Skin barrier 232
            • 4.3.2.3 Deodorant 234
            • 4.3.2.4 Irrigation products 236
            • 4.3.2.5 Other ostomy care 238

          5 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY UTILITY 241

          • 5.1 INTRODUCTION 241
          • 5.2 SECURITY AND LEAKAGE CONTROL 244
          • 5.3 ODOR CONTROL 248
          • 5.4 PROTECTION AND CLEANSING 250
          • 5.5 IRRIGATION PRODUCTS 253

          6 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY APPLICATION 255

          • 6.1 INTRODUCTION 255
          • 6.2 WOMEN HEALTH RELATED 258
          • 6.3 GI TRACT DISEASES 261
          • 6.4 ONCOLOGY 265
          • 6.5 NEUROLOGICAL CONDITIONS 267
          • 6.6 URINOGENITAL DISEASES 270
          • 6.7 OTHER DISEASES 272

          7 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY END-USER 275

          • 7.1 INTRODUCTION 275
          • 7.2 HOSPITALS 278
          • 7.3 HOMECARE 281
          • 7.4 OTHER END-USER 284

          8 REGIONAL ANALYSIS 287

          • 8.1 INTRODUCTION 287
          • 8.2 NORTH AMERICA 291
            • 8.2.1 U.S. 313
            • 8.2.2 REST OF NORTH AMERICA 319
          • 8.3 EUROPE 325
            • 8.3.1 GERMANY 346
            • 8.3.2 FRANCE 352
            • 8.3.3 U.K. 357
            • 8.3.4 REST OF EUROPE 363
          • 8.4 APAC 368
            • 8.4.1 JAPAN 389
            • 8.4.2 CHINA 395
            • 8.4.3 INDIA 400
            • 8.4.4 REST OF APAC 405
          • 8.5 ROW 412
            • 8.5.1 BRAZIL 432
            • 8.5.2 REST OF LATAM 437
            • 8.5.3 MIDDLE EAST & AFRICA 442

          9 COMPETITIVE LANDSCAPE 447

          • 9.1 INTRODUCTION 447
          • 9.2 ACQUISITION AND PARTNERSHIP 448
          • 9.3 PRODUCT LAUNCH 451
          • 9.4 PRODUCT APPROVAL 453
          • 9.5 OTHERS 454

          10 MAJOR COMPANIES 455

          • 10.1 COLOPLAST A/S 455
            • 10.1.1 OVERVIEW 455
            • 10.1.2 FINANCIALS 456
            • 10.1.3 PRODUCT PORTFOLIO 459
            • 10.1.4 KEY DEVELOPMENTS 460
            • 10.1.5 BUSINESS STRATEGY 461
            • 10.1.6 SWOT ANALYSIS 462
          • 10.2 CONVATEC GROUP PLC 463
            • 10.2.1 OVERVIEW 463
            • 10.2.2 FINANCIALS 464
            • 10.2.3 PRODUCT PORTFOLIO 467
            • 10.2.4 KEY DEVELOPMENTS 468
            • 10.2.5 BUSINESS STRATEGY 469
            • 10.2.6 SWOT ANALYSIS 470
          • 10.3 DOMTAR CORPORATION 471
            • 10.3.1 OVERVIEW 471
            • 10.3.2 FINANCIALS 472
            • 10.3.3 PRODUCT PORTFOLIO 475
            • 10.3.4 KEY DEVELOPMENTS 475
            • 10.3.5 BUSINESS STRATEGY 476
            • 10.3.6 SWOT ANALYSIS 477
          • 10.4 ESSITY AKTIEBOLAG (PUBL) 478
            • 10.4.1 OVERVIEW 478
            • 10.4.2 FINANCIALS 479
            • 10.4.3 PRODUCT PORTFOLIO 483
            • 10.4.4 KEY DEVELOPMENTS 483
            • 10.4.5 BUSINESS STRATEGY 484
            • 10.4.6 SWOT ANALYSIS 485
          • 10.5 HOLLISTER INCORPORATED 486
            • 10.5.1 OVERVIEW 486
            • 10.5.2 FINANCIALS 486
            • 10.5.3 PRODUCT PORTFOLIO 487
            • 10.5.4 KEY DEVELOPMENTS 490
            • 10.5.5 BUSINESS STRATEGY 491
            • 10.5.6 SWOT ANALYSIS 492
          • 10.6 KIMBERLY-CLARK CORPORATION 493
            • 10.6.1 OVERVIEW 493
            • 10.6.2 FINANCIALS 494
            • 10.6.3 PRODUCT PORTFOLIO 497
            • 10.6.4 KEY DEVELOPMENTS 497
            • 10.6.5 BUSINESS STRATEGY 498
            • 10.6.6 SWOT ANALYSIS 499
          • 10.7 MEDTRONIC, PLC. 500
            • 10.7.1 OVERVIEW 500
            • 10.7.2 FINANCIALS 501
            • 10.7.3 PRODUCT PORTFOLIO 505
            • 10.7.4 KEY DEVELOPMENTS 505
            • 10.7.5 BUSINESS STRATEGY 506
            • 10.7.6 SWOT ANALYSIS 507
          • 10.8 ONTEX 508
            • 10.8.1 OVERVIEW 508
            • 10.8.2 FINANCIALS 509
            • 10.8.3 PRODUCT PORTFOLIO 512
            • 10.8.4 KEY DEVELOPMENTS 512
            • 10.8.5 BUSINESS STRATEGY 513
            • 10.8.6 SWOT ANALYSIS 514
          • 10.9 PAUL HARTMANN AG 515
            • 10.9.1 OVERVIEW 515
            • 10.9.2 FINANCIALS 516
            • 10.9.3 PRODUCT PORTFOLIO 519
            • 10.9.4 KEY DEVELOPMENTS 519
            • 10.9.5 BUSINESS STRATEGY 520
            • 10.9.6 SWOT ANALYSIS 521
          • 10.10 UNICHARM CORPORATION 522
            • 10.10.1 OVERVIEW 522
            • 10.10.2 FINANCIALS 523
            • 10.10.3 PRODUCT PORTFOLIO 526
            • 10.10.4 KEY DEVELOPMENTS 528
            • 10.10.5 BUSINESS STRATEGY 528

    Incontinence and Ostomy Care consist of products that are essential for patients with incontinence and stoma surgeries. Increasing in aged population, increased utilization of the various incontinence and ostomy care products for the management or treatment of different types of incontinence and ostomy surgeries among the patients, elevating inclination of the value centric global patient pool towards the technologically advanced incontinence and ostomy care products with better therapeutic outcomes and also increasing awareness about the disease and the availability of the wide varieties of products to manage or treat the disease conditions fuelling the incontinence and ostomy care global market.
    As estimated by IQ4I Research, the incontinence and ostomy care global market is expected to reach $24,577.9 million by 2026 growing at a mid single digit from 2019 to 2026 due to increase in population prone to aging related medical conditions, growing prevalence of medical conditions such as women health related conditions (e.g. childbirth, menopause), inflammatory bowel diseases (crohn’s disease and ulcerative colitis), neurological diseases (multiple sclerosis, Parkinson’s disease), oncology (colorectal and prostate cancer) and others diseases, increasing awareness & acceptance of the condition of incontinence & ostomy, growing economies and increasing demand for better healthcare facilities in emerging markets. The incontinence and ostomy market is segmented by product, utility, application, end-user and geography.
    Based on the product type, the incontinence and ostomy care global market is segmented into incontinence and ostomy care. Incontinence care segment is the largest and fastest growing product segment is expected to grow at a mid single digit CAGR from 2019 to 2026. Based on disease type, the incontinence care market is classified into urinary incontinence and fecal incontinence, urinary incontinence is accounted for largest and fastest growing segment is expected to grow at a mid single digit CAGR from 2019 to 2026. Based on the product type, incontinence care market is segment into disposables and implantable device. Among these segments, disposables segment accounted for the largest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Implant devices is fastest growing segment at a high single digit CAGR from 2019 to 2026. In the disposable global market by type, the adult diapers segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit from 2019 to 2026. Incontinence Catheter is fastest growing segment at a mid single digit CAGR from 2019 to 2026. Among the overall adult diaper market by type, underwear & briefs segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Pads & Guards is fastest growing segment at a mid single digit CAGR from 2019 to 2026. Implant devices by product type, Sacral Nerve Stimulation (SNS) segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Slings is fastest growing segment at a CAGR of high single digit from 2019 to 2026.
    Ostomy care is growing at low single digit from 2019 to 2026. The ostomy care global market by surgery type, colostomy segment is the largest and fastest growing product segment expected to grow at low single digit CAGR from 2019 to 2026 due to increase prevalence of targeted diseases such as cancer and GI tract diseases. Based on product type the ostomy care global market is classified into ostomy bags, skin barriers, deodorants, irrigation products and others accessories like ostomy tape, removers, belts, detergents, stoma implants and stoma caps. The ostomy bags segment is the largest and fastest growing product segment and expected to grow at low single digit CAGR from 2019 to 2026. Among the ostomy bags, two-piece ostomy bags is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026 due to technological innovations in their designs.
    Based on the utility, the incontinence and ostomy care global market is segmented into security & leakage control, protection & cleansing, odor control and irrigation products. Security & Leakage control segment is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026 due to increasing use of security and leakage control device for incontinence and stoma management and increasing technological advancement in these devices to increase efficiency.
    Based on application, the incontinence and ostomy global market is segmented into women health related, neurological conditions, oncology, urinogenital diseases, GI Tract diseases and others. Women health related segment accounted for the largest revenue in 2019 and is expected to grow at mid single digit CAGR from 2019 to 2026 due to women are more prone to incontinence related problems such as damage to nerve controlling urine or fecal urge during childbirth and impaired sphincter function which is a result of pelvic floor weakness which in turn may be due to pregnancy & vaginal birth, surgeries related to uterus, aging and weakness of the connective tissue. Oncology segment is the fastest growing segment and is projected to grow at mid single digit CAGR from 2019 to 2026 due to increase in the prevalence of prostate, colorectal and bladder cancers.
    Based on end-users of incontinence and ostomy care market has been segmented into hospitals, home care, and others that consist of clinics and research institutes. Homecare accounted for the largest revenue in 2019 and it expected to grow at mid single digit CAGR from 2019 to 2026 due to the availability of better and technologically advanced personalized incontinence and stoma management products. The hospitals is fastest growing segment and is projected to grow at a mid single digit CAGR from 2019 to 2026 due to increasing availability various advanced minimally invasive treatments.
    Based on the region, the incontinence and ostomy care global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & Africa). Europe accounted for the largest revenue in 2019 and is expected to growing at a low single digit CAGR from 2019 to 2026 due to increasing prevalence of targeted disease in the region, escalating geriatric population, increasing penetration and adoption of advanced products and increasing R&D spending for developing innovative and technologically advanced products.
    The Asia-Pacific is the fastest growing region in incontinence and ostomy care market and is expected to grow at a high single digit CAGR from 2019 to 2026 due to elevating increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, elevating demand for better healthcare facilities from the population in the region and growing economies of the region, availability of various kinds of incontinence and ostomy management products and increasing medical tourism prospects of the region.
    Some of the major players in incontinence and ostomy care market include Essity AB (Sweden), Coloplast A/S (Denmark), Kimberly-Clark Corporation (U.S.), Unicharm Corporation (Japan), ConvaTec Group Plc (U.K.), B. Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Ontex (Belgium), Paul Hartmann AG (Germany), Procter & Gamble Company (U.S.), Hollister Incorporated (U.S.), Salts Healthcare (U.K.), First Quality Enterprises, Inc. (U.S.), Abena A/S (Denmark), Becton, Dickinson and Company (U.S.), Medline Industries, Inc., (U.S.), Domtar Corporation (U.S.) and others.

    The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
    • North America
    o U.S.
    o Rest of North America
    • Europe
    o Germany
    o U.K.
    o France
    o Rest of Europe
    • Asia-Pacific
    o Japan
    o China
    o Indian
    o Rest of APAC
    • Rest of the World (RoW)
    o Brazil
    o Rest of LATAM
    o Middle East and Africa

    Buy now